Special Reports

[  72 Special Reports found     |    Pages:       1 2 3 4 >>  ]

• Antibody-Drug Conjugates Stage a Comeback
• 3/9/2010
• Technology improvements yield fresh line of anticancer clinical candidates. Full Report
• Antibody-Drug Conjugates to Fight Cancer
• 3/2/2010
• While mAbs have been extremely successful, these empowered antibodies are touted as the next big blockbusters. Full Report
• Examining Both Sides of the Sirtuin Coin
• 2/22/2010
• Jury is still out on whether inhibition and/or activation can treat neurodegenerative disorders. Full Report
• Sirtuins: Antiaging Medicines or Marketing?
• 2/16/2010
• GSK shelled out $720 million for Sirtris but admits that the new science needs validation. Full Report
• Roche Takes a Stab at Getting mAbs Under the Skin
• 2/1/2010
• Firm is testing Herceptin SC in Phase III and expects to couple it with a user-friendly delivery device. Full Report
• Advancing Stem Cell Therapies for Multiple Sclerosis
• 1/25/2010
• UKSCF partners with MS Society to financially support clinical development. Full Report
• Cancer Cell Line Identity Crisis
• 1/21/2010
• Researchers weigh in on the impact of incorrectly labeled cell lines on cancer research and drug development. Full Report
• Biotech Financing Overview and Trends from Last Year’s Fourth Quarter
• 1/19/2010
• Biotechs are lining up to go public after a long wait. Full Report
• Stem Cell Utility Limited by Lack of Ethnic Diversity
• 1/15/2010
• Researchers stress the need to derive new lines that represent populations missing from currently available hESCs. Full Report
• Reporting from J.P. Morgan Healthcare Conference
• 1/14/2010
• Drug companies developing companion diagnostics is just one of the trends highlighted at the meeting. Full Report
• 2009 in Review: Headline-Making Stories in the Biotech Industry
• 1/6/2010
• Even though last year was marred by the economic crash, the life science sector showed significant progress. Full Report
• Part 2—Finding Newer Molecular Targets for Antidepressants
• 12/30/2009
• Creating better mouse models is key to developing more effective drugs and understanding how current treatments work. Full Report
• Part 1—Questions Remain about Whether Antidepressants Really Work
• 12/24/2009
• Significant side effects continue to plague currently available drugs, and efficacy is only seen in the most severely depressed patients. Full Report
• Part 2—Tips for Biotech/Pharma Complainants and Respondents When Going to the ITC
• 12/22/2009
• Going to the ITC provides needed tools like foreign discovery that are not available in a district court. Full Report
• Part 1—The U.S. International Trade Commission and Intellectual Property
• 12/18/2009
• Advantages of going to the ITC over U.S. courts include speedy resolutions and remedies that prohibit infringers from the entire U.S. market. Full Report
• Big Pharma Adopting Orphan Drug Strategy
• 12/14/2009
• Potential for profitability in small markets is beginning to lure companies away from the failing blockbluster model. Full Report
• Early-Stage Investors Hedge Their Bets with Medical Devices
• 12/10/2009
• VCs are looking for a quicker return on their investments with less risk involved. Full Report
• Obesity Therapies Show Lackluster Efficacy Results
• 12/3/2009
• A potential market of $10 billion annually in the U.S. alone is keeping companies in the race to develop better drugs. Full Report
• Poniard’s Fortunes Likely Rest on Picoplatin
• 11/25/2009
• Disappointing Phase III results in SCLC but promising Phase II results in colorectal cancer make company’s future uncertain. Full Report
• New Uncertainty Regarding Disclosure of Adverse Effects
• 11/23/2009
• Recent Matrixx Initiatives decision muddies requirements set forth in Carter-Wallace over a decade ago. Full Report

[  72 Special Reports found     |    Pages:       1 2 3 4 >>  ]

visit the Career Center

• GEN Webinars: Implementing a Successful Process Analytical Technology Strategy
• Date: Wednesday, March 10, 2010
• In this webinar you will learn about the importance of choosing and implementing forward-looking tec ...learn more.

• Mar 30 2010
• High-Content Protein Microarrays for Biomarker Discovery and Therapeutic Response Monitoring
• sponsored by Invitrogen
• Mar 25 2010
• Advanced Platforms for Discovery and Validation of Protein Therapeutics
• sponsored by Invitrogen
• Mar 23 2010
• Multi-milligram to Gram Scale Protein Production in Mammalian Cells in 5 Days
• sponsored by Invitrogen
• Mar 16 2010
• The Search for a True Identity : Defining Characteristics of Bona Fide Human iPS Cells
• sponsored by Stemcell Technologies

view all webinars

ADVERTISEMENT

• Listen
• Save
• Comment
• View All

INTERVIEW: WATER-WISE PLANTS FOR A WORLD GROWING WARMER - Interview with Julian Schroeder, Ph.D., Professor of Biology, University of California, San Diego ...MORE

ADVERTISEMENT